SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CNSI Cambridge Neuroscience

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: TheSlowLane who wrote (35)11/25/1996 8:19:00 PM
From: James Silverman   of 675
 
Paul Ferguson wrote:
CNSI is on the move! It looks like interest is warming up on CNSI. It has hit 14 today. I talked to a friend of mine who is a glaucoma specialist. He says that it looks promising. If the drug is fundamentally the same s Cerestat, CNSI may be able to bring it to market quickly, bypassing clinical trials.
===============================================
Paul,
This speculation is way off the mark. First, the drug would have to undergo extensive clinicals regardless. Second, it will not be fundamentally the same as Cerestat. Cerestat is hallucinogenic. We'd have these elderly people getting treated for Glaucoma tripping out!!
Expect the development of this to take YEARS. Its good that they are progressing into other areas. CNSI has been discounted due to the view that they are a one product company. This should help. Of course the key is an expedient finishing of Cerestat clinicals and an approval thereafter.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext